Coordinatore | THE FOUNDATION FOR MEDICAL RESEARCHINFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV
Organization address
address: WEIZMANN STREET 6 contact info |
Nazionalità Coordinatore | Israel [IL] |
Sito del progetto | http://www.v-time.eu/index.php/en/ |
Totale costo | 7˙477˙391 € |
EC contributo | 5˙781˙956 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2011-two-stage |
Funding Scheme | CP-FP |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-01-01 - 2015-12-31 |
# | ||||
---|---|---|---|---|
1 |
THE FOUNDATION FOR MEDICAL RESEARCHINFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV
Organization address
address: WEIZMANN STREET 6 contact info |
IL (Tel Aviv) | coordinator | 1˙043˙090.00 |
2 |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address
address: GEERT GROOTEPLEIN NOORD 9 contact info |
NL (NIJMEGEN) | participant | 963˙652.00 |
3 |
UNIVERSITA DEGLI STUDI DI GENOVA
Organization address
address: VIA BALBI 5 contact info |
IT (GENOVA) | participant | 685˙547.00 |
4 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 680˙190.00 |
5 |
UNIVERSITY OF NEWCASTLE UPON TYNE
Organization address
address: Kensington Terrace 6 contact info |
UK (NEWCASTLE UPON TYNE) | participant | 673˙469.60 |
6 |
ADVANCED DRUG DEVELOPMENT SERVICES - ADDS SRO
Organization address
address: JANA UHRA 168/10 contact info |
CZ (BRNO) | participant | 600˙408.20 |
7 |
INITION LIMITED
Organization address
address: CURTAIN ROAD 23 contact info |
UK (LONDON) | participant | 461˙300.00 |
8 |
BEACON TECH LTD
Organization address
address: OPPENHEIMER STREET 5 contact info |
IL (REHOVOT) | participant | 402˙500.00 |
9 |
UNIVERSITA DEGLI STUDI DI SASSARI
Organization address
address: PIAZZA UNIVERSITA 21 contact info |
IT (SASSARI) | participant | 271˙800.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Falls are a major public health concern that directly affects millions of elderly Europeans, the healthcare system, and the adult children and caregivers of older people. The V-TIME approach combines cutting edge technology with emerging concepts from gerontology, neuroscience and rehabilitation to reduce fall risk in a unique way. The V-TIME multi-modal intervention consists of treadmill training (TT) that promotes walking abilities and physical fitness. A key novel addition is the simultaneous use of a virtual reality (VR) environment that challenges, implicitly teaches and enhances cognitive skills that facilitate the safe execution of many activities of daily living: visual scanning, planning, dual tasking abilities, and obstacle negotiation. Exciting pilot studies support the idea that TT augmented with VR (TTVR) addresses the limitations of existing fall prevention interventions. Via TTVR, V-TIME offers task-specific training in a motivating and safe environment that can readily be reproduced and standardized. The major goal of the current proposal is to establish the beneficial effects of V-TIME training in a large (n=300) and diverse group of elderly via a multi-centre, prospective randomized controlled trial. Outcomes include post-training 6 month fall incidence rates (the primary outcome), gait, physical activity (e.g., steps walked in 7 days), cognitive function, quality of life, and neuroimaging measures (fNIRS, fMRI). The effects of dosing and an extension phase will be examined (n=60). The consortium brings together world leaders in ageing, neuroscience, rehabilitation and VR technology to test a new therapy that may dramatically reduce the negative costs of falls, financial and other. The RCT is designed to show that V-TIME offers a significant and clinically relevant greater benefit compared to current clinical management; to probe brain plasticity; and to establish efficacy on fall risk, mobility, cognitive function, and functional independence.'
Search for new therapeutic agents against complicated obesity by reprofiling existing drugs
Read MoreMissed Opportunities in Maternal and Infant Health: reducing maternal and newborn mortality and morbidity in the year after childbirth through combined facility- and community-based interventions
Read More